Stifel Downgrades Kura Oncology(KURA.US) to Hold Rating, Cuts Target Price to $19
Kura Oncology Downgraded to Hold From Buy at Stifel
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG)
Kura Oncology Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $32 Price Target
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Aquestive Therapeutics (AQST)
Kura Oncology Price Target Maintained With a $37.00/Share by Wedbush
Kura Oncology (KURA) Gets a Buy From Stifel Nicolaus
Scotiabank Reaffirms Their Hold Rating on Kura Oncology (KURA)
Buy Rating Affirmed for Kura Oncology Amid Positive Clinical and Financial Developments
Buy Rating on Kura Oncology's Ziftomenib for Its Dual Promise in Oncology and Diabetes Management
Kura Oncology Analyst Ratings
Kura Oncology Analyst Ratings
Kura Oncology Analyst Ratings
Buy Rating Affirmed for Kura Oncology Amidst Promising Ziftomenib Trials and Strategic Advantages
Kura Oncology Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Tourmaline Bio (TRML)
Kura Oncology Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Relay Therapeutics (RLAY), Kura Oncology (KURA)
Kura Oncology Analyst Ratings